Aspirin/Dihydroxyaluminium Aminoacetate/Heavy Magnesium Carbonate

阿司匹林/甘羟铝/重质碳酸镁

Report date: 2026/02/02 20:01:46

Base Information

Drug NameAspirin/Dihydroxyaluminium Aminoacetate/Heavy Magnesium Carbonate
Drug Alias Name铝镁匹林片(Ⅱ)
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsMucocutaneous Lymph Node SyndromeThrombosisThromboembolism +[9] 
Global Approved IndicationsMucocutaneous Lymph Node SyndromeThromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsYes AspirinHeavy Magnesium Carbounate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHuadong Medicine (Xi'An) Bodyguard Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesHuadong Medicine (Xi'An) Bodyguard Pharmaceutical Co Ltd
Active IndicationsMucocutaneous Lymph Node SyndromeThromboembolismCommon Cold
Inactive IndicationsThrombosisMyocardial InfarctionAngina, Stable +[6] 

Other Information

ATC CodeN/A
Related LinksN/A